The MRC funding will help with the next steps, including equipment needed to manufacture experimental mRNA cancer vaccines and test whether the AI’s predictions work in patient samples. The aim is to determine whether vaccine targets selected by AI can generate strong anti-cancer immune responses.
Source link
Top News
Tuesday , 20 October 2026
Tuesday , 20 October 2026
Share
Explore more
Related Articles
Artificial intelligence
Microsoft says AI agents are like insider threats as ‘frontier models can’t be trusted’
Microsoft on Monday introduced new security features designed to protect enterprises from...
Artificial intelligence
Doosan Robotics appoints AI leaders: what it means for Doosan Robotics stock
Doosan Robotics (ISIN KR7454910001) introduced a new leadership structure on October 19,...
Artificial intelligence
Report: Microsoft Withdraws from UK AI Data Center Project | Reason: Power Connection Issues
In three lines The British newspaper The Telegraph and others reported that...
Artificial intelligence
Machine learning finds patients with high-risk extubation failure
October 19, 2026 4 min read Add topic to...
Leave a comment